aTYR PHARMA INC Finance Lease, Liability, to be Paid, Year Four
aTYR PHARMA INC (ATYR) had Finance Lease, Liability, to be Paid, Year Four of $264.00 thousand as of 2023-12-31, per its 10-K filed 2024-03-14.
Discontinued › Notes › Commitment and Contingencies › Finance Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour · last filed 2024-03-14
- 2023-12-31: Finance Lease, Liability, to be Paid, Year Four $264.00K.
- 2023-09-30: Finance Lease, Liability, to be Paid, Year Four $213.00K.
- 2023-06-30: Finance Lease, Liability, to be Paid, Year Four $203.00K.
- 2023-03-31: Finance Lease, Liability, to be Paid, Year Four $185.00K.
| Period end | Finance Lease, Liability, to be Paid, Year Four |
|---|---|
| 2023-12-31 | $264.00K 10-K · filed 2024-03-14 |
| 2023-09-30 | $213.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $203.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $185.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $395.00K 10-K · filed 2023-03-14 |
| 2022-09-30 | $223.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $97.00K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |